Our results are in line with those of Hue et al. that recently identified a plasma chemokine signature in COVID-19 ARDS patients (CXCL10, GMCSF and IL-10) which was associated with mortality (9). The gene discussed is CSF2; the disease is acute respiratory distress syndrome.